Adalimumab biosimilar market shares have steadily increased, but challenges remain due to pricing strategies and limited government support, according to the Samsung Bioepis report.
Insulin Biosimilar MarketThe global insulin biosimilar market is on track for significant expansion, with an estimated valuation of approximately USD 3,008.0 million in 2024. Exhibiting a year-on-year ...
While all five FTC commissioners voted to issue the Report, both Republican commissioners also issued separate statements expressing concerns about specific aspects of the Report. In a separately ...
CHEYENNE — Following the presence of the Center for Technology and Civic Life at the Wyoming Association of County Officers’ meeting in Rock Springs on Sept. 25, Wyoming Secretary of State Chuck Gray ...
In the QWINT-1 phase 3 clinical trial, 796 participants were randomly selected to receive either the weekly efsitora injection or a daily injection of insulin glargine for 52 weeks. At the end of ...